Old Web
English
Sign In
Acemap
>
authorDetail
>
Holly Baughman
Holly Baughman
Immunology
Immunogenicity
Biology
Antibody titer
Diarrhea
3
Papers
48
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
2019
Vaccine
David I. Bernstein
Marcela F. Pasetti
Rebecca C. Brady
Amanda D. Buskirk
Rezwanul Wahid
Michelle Dickey
Mitchell B. Cohen
Holly Baughman
Jill El-Khorazaty
Nicole Maier
Marcelo B. Sztein
Shahida Baqar
A. Louis Bourgeois
Show All
Source
Cite
Save
Citations (11)
A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei
2018
Vaccine
Robert W. Frenck
Shahida Baqar
William A. Alexander
Michelle Dickey
Monica M. McNeal
Jill El-Khorazaty
Holly Baughman
Amy Hoeper
Shoshana Barnoy
Akamol E. Suvarnapunya
Robert W. Kaminski
Malabi M. Venkatesan
Show All
Source
Cite
Save
Citations (10)
Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax
2016
Clinical and Vaccine Immunology
Wilbur H. Chen
Marcela F. Pasetti
Rajan P. Adhikari
Holly Baughman
Robin Douglas
Jill El-Khorazaty
Nancy Greenberg
Frederick W. Holtsberg
Grant C. Liao
Mardi Reymann
Xiaolin Wang
Kelly L. Warfield
M. Javad Aman
Show All
Source
Cite
Save
Citations (27)
1